Leap Therapeutics (LPTX) Misses Q3 EPS by 8c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.08).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Morgan Stanley Starts Target Hospitality (TH) at Overweight
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• RBC Capital Upgrades CAE Inc. (CAE:CN) (CAE) to Outperform